Evidence map›Paper›PMID 36192789›Full record

ArticleJournal of cheminformatics2022

Augmented Hill-Climb increases reinforcement learning efficiency for language-based de novo molecule generation.

Morgan Thomas, Noel M O'Boyle, Andreas Bender, Chris de Graaf

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Applying Deep-Learning-DrivenJournal of medicinal chemistry · 2026
    Article
  5. Review
  6. MolOrgGPT:Journal of chemical information and modeling · 2026
    Article
  7. Article
  8. Review
  9. Test-Time Training Scaling Laws for Chemical Exploration in Drug Design.Journal of chemical information and modeling · 2025
    Article
  10. REINFORCE-ING Chemical Language Models for Drug Discovery.Journal of chemical information and modeling · 2025
    Article
  11. Review
  12. Generative Deep Learning for de Novo Drug Design─A Chemical Space Odyssey.Journal of chemical information and modeling · 2025
    Review
  13. Identification of nanomolar adenosine ANature communications · 2025
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Morgan ThomasCentre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK. mct50@cam.ac.uk.
Noel M O'BoyleComputational Chemistry, Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG, UK.
Andreas BenderCentre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.
Chris de GraafComputational Chemistry, Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A plethora of AI-based techniques now exists to conduct de novo molecule generation that can devise molecules conditioned towards a particular endpoint in the context of drug design. One popular approach is using reinforcement learning to update a recurrent neural network or language-based de novo molecule generator. However, reinforcement learning can be inefficient, sometimes requiring up to 10

Indexed as

AIArtificial intelligenceDeep learningDe novo designGenerative modelsHill-ClimbMolecular dockingRecurrent neural networkREINFORCEReinforcement learningREINVENTSBDDStructure-based drug design

Identifiers

PMID36192789
PMCPMC9531503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.